Related references
Note: Only part of the references are listed.P2Y purinergic receptors: New targets for analgesic and antimigraine drugs
Giulia Magni et al.
BIOCHEMICAL PHARMACOLOGY (2013)
The role of glutamate release mediated by extrasynaptic P2X7 receptors in animal models of neuropathic pain
Romeo D. Ando et al.
BRAIN RESEARCH BULLETIN (2013)
The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice
Cecilia Csoelle et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
K+ depolarization evokes ATP, adenosine and glutamate release from glia in rat hippocampus: a microelectrode biosensor study
A. Heinrich et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity
Robert E. Sorge et al.
NATURE MEDICINE (2012)
In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3β and secretases
Juan Ignacio Diaz-Hernandez et al.
NEUROBIOLOGY OF AGING (2012)
A Safe, Blood-Brain Barrier Permeable Triphenylmethane Dye Inhibits Annyloid-β Neurotoxicity by Generating Nontoxic Aggregates
H. Edward Wong et al.
ACS CHEMICAL NEUROSCIENCE (2011)
Receptor localization, native tissue binding and ex vivo occupancy for centrally penetrant P2X7 antagonists in the rat
S. L. Able et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Calcitonin Gene-Related Peptide-Mediated Enhancement of Purinergic Neuron/Glia Communication by the Algogenic Factor Bradykinin in Mouse Trigeminal Ganglia from Wild-Type and R192Q Cav2.1 Knock-In Mice: Implications for Basic Mechanisms of Migraine Pain
Stefania Ceruti et al.
JOURNAL OF NEUROSCIENCE (2011)
Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson's disease
Zsuzsanna Hracsko et al.
MOLECULAR NEURODEGENERATION (2011)
Inhibition of Neuronal Voltage-Gated Sodium Channels by Brilliant Blue G
Sooyeon Jo et al.
MOLECULAR PHARMACOLOGY (2011)
Diencephalic and brainstem mechanisms in migraine
Simon Akerman et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Emerging migraine treatments and drug targets
Jes Olesen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Involvement of microglial P2X7 receptors and downstream signaling pathways in long-term potentiation of spinal nociceptive responses
Yu-Xia Chu et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
A comparative analysis of the activity of ligands acting at P2X and P2Y receptor subtypes in models of neuropathic, acute and inflammatory pain
R. D. Ando et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice
E. A. Bates et al.
CEPHALALGIA (2010)
Global prevalence of chronic migraine: A systematic review
J. L. Natoli et al.
CEPHALALGIA (2010)
Involvement of temporomandibular joint P2X3 and P2X2/3 receptors in carrageenan-induced inflammatory hyperalgesia in rats
Juliana Maia Teixeira et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Peripheral origin of IL-1β production in the rodent hippocampus under in vivo systemic bacterial lipopolysaccharide (LPS) challenge and its regulation by P2X7 receptors
C. Csoelle et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Familial hemiplegic migraine CaV2.1 channel mutation R192Q enhances ATP-gated P2X3 receptor activity of mouse sensory ganglion neurons mediating trigeminal pain
Asha Nair et al.
MOLECULAR PAIN (2010)
AMPA- and P2X7-receptor-mediated facilitation of [3H]D-aspartate release from nerve terminals isolated from the rat caudal brainstem
M. D'Amico et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
The relevance of preclinical research models for the development of antimigraine drugs: Focus on 5-HT1B/1D and CGRP receptors
Saurabh Gupta et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus
Marie-Luise Sixt et al.
BRAIN (2009)
Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration
Miguel Diaz-Hernandez et al.
FASEB JOURNAL (2009)
An in vivo evaluation of Brilliant Blue G in animals and humans
M. Remy et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Mechanisms mediating the enhanced gene transcription of P2X3 receptor by calcitonin gene-related peptide in trigeminal sensory neurons
Manuela Simonetti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Prevalence and characteristics of allodynia in headache sufferers - A population study
M. E. Bigal et al.
NEUROLOGY (2008)
Cortical spreading depression releases ATP into the extracellular space and purinergic receptor activation contributes to the induction of ischemic tolerance
Sarah C. Schock et al.
BRAIN RESEARCH (2007)
Neutralization of nerve growth factor induces plasticity of ATP-sensitive P2X3 receptors of nociceptive trigeminal ganglion neurons
Marianna D'Arco et al.
JOURNAL OF NEUROSCIENCE (2007)
P2x7-related modulation of pathological nociception in rats
S. McGaraughty et al.
NEUROSCIENCE (2007)
Neuronal somatic ATP release triggers neuron-satellite glial cell communication in dorsal root ganglia
X. Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The global burden of headache: a documentation of headache prevalence and disability worldwide
L. J. Stovner et al.
CEPHALALGIA (2007)
A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino)methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat
Prisca Honore et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Delayed upregulation of ATP P2X3 receptors of trigeminal sensory neurons by calcitonin gene-related peptide
Elsa Fabbretti et al.
JOURNAL OF NEUROSCIENCE (2006)
P2X7 receptors in the nervous system
Beata Sperlagh et al.
PROGRESS IN NEUROBIOLOGY (2006)
Trigeminal P2X3 receptor expression differs from dorsal root ganglion and is modulated by deep tissue inflammation
R Ambalavanar et al.
PAIN (2005)
Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
IP Chessell et al.
PAIN (2005)
Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches
G Sances et al.
CEPHALALGIA (2004)
Bioactivation of nitroglycerin to nitric oxide (NO) and S-nitrosothiols in the rat liver and evaluation of the coexisting hypotensive effect
M Sokolowska et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2004)
The effect of propranolol on glyceryltrinitrate-induced headache and arterial response
JF Tvedskov et al.
CEPHALALGIA (2004)
The prophylactic effect of valproate on glyceryltrinitrate induced migraine
JF Tvedskov et al.
CEPHALALGIA (2004)
Nitroglycerin induces migraine headache and central sensitization phenomena in patients with migraine without aura: a study of laser evoked potentials
M de Tommaso et al.
NEUROSCIENCE LETTERS (2004)
Effect of resiniferatoxin on the noxious heat threshold temperature in the rat:: a novel heat allodynia model sensitive to analgesics
R Almási et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Brainstem activation specific to migraine headache
A Bahra et al.
LANCET (2001)
Altered cytokine production in mice lacking P2X7 receptors
M Solle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Activation of trigeminovascular neurons by glyceryl trinitrate
GA Lambert et al.
BRAIN RESEARCH (2000)
Brilliant Blue G selectively blocks ATP-gated rat P2X7 receptors
LH Jiang et al.
MOLECULAR PHARMACOLOGY (2000)
Share Paper
